This contract expires in 530 days (Mar 31, 2028).

THE EMMES COMPANY, LLC - OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).

PIID: 75N95024F00007Solicitation ID: 75N95024F00007

Signed Date: Aug 14, 2024Effective Date: Aug 15, 2024End Date: Closes in 530 days

Award $

$1.9M

Vendor

THE EMMES COMPANY, LLC

NAICS

541715

Signed Date

Aug 14, 2024

Key Details

Dollars Obligated

$1.9M

Base & All Options

$1.9M

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Parent IDIQ (PIID)

75N95022D00017

Product Service Code

AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

ROCKVILLE, MD

Description

OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).

Context & Analysis

On Aug 14, 2024, Department of Health and Human Services obligated $1,860,579 to THE EMMES COMPANY, LLC for optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (ctn-0100). august 15, 2024 to march 31, 2028. n01da-22-2253. task order no. 75n95024f00007 (to23)…. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition. Performance is located in ROCKVILLE, MD. The contract is scheduled through Mar 31, 2028 — approximately 18 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.